Diastolic heart failure

Cardiovascular Research

Volumn 45, Issue 4, 2000, Pages 813-825

  Mandinov, Lazar ^a   Eberli, Franz R ^a   Seiler, Christian ^a   Hess, Otto M ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Heart failure

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE DONOR;

AGING; CORONARY ARTERY DISEASE; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART MUSCLE COMPLIANCE; HEART MUSCLE RELAXATION; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; REVIEW;

DIASTOLE; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; RADIONUCLIDE ANGIOGRAPHY; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033974469     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00399-5     Document Type: Review

References (75)

1. Bonow R.O., Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management [see comments]. Ann Intern Med. 117:1992;502-510.
2. Cregler L.L., Georgiou D., Sosa I. Left ventricular diastolic dysfunction in patients with congestive heart failure. J Natl Med Assoc. 83:1991;49-52.
3. Brogan W.Cd., Hillis L.D., Flores E.D., Lange R.A. The natural history of isolated left ventricular diastolic dysfunction. Am J Med. 92:1992;627-630.
4. Vasan R.S., Benjamin E.J., Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 26:1995;1565-1574.
5. Cohn J.N., Johnson G. Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation. 81:1990;Iii48-53.
6. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 33:1999;1948-1955.
7. Fagerberg B. [National and international guidelines ignore significant cause of heart failure. Diastolic dysfunction is often the cause of heart failure in the elderly and in women]. Lakartidningen. 95:1998;5305-5308.
8. Marantz P.R., Tobin J.N., Derby C.A., Cohen M.V. Age-associated changes in diastolic filling: Doppler E/A ratio is not associated with congestive heart failure in the elderly. South Med J. 87:1994;728-735.
9. Zabalgoitia M., Rahman S.N., Haley W.E., et al. Comparison in systemic hypertension of left ventricular mass and geometry with systolic and diastolic function in patients <65 to 65 years of age. Am J Cardiol. 82:1998;604-608.
10. Zabalgoitia M., Ur Rahman S.N., Haley W.E., et al. Role of left ventricular hypertrophy in diastolic dysfunction in aged hypertensive patients. J Hypertens. 15:1997;1175-1179.
11. Brutsaert D.L., Sys S.U., Gillebert T.C. Diastolic failure: pathophysiology and therapeutic implications [published erratum appears in J Am Coll Cardiol 1993, 22(4) 1272]. J Am Coll Cardiol. 22:1993;318-325.
12. Grossman W. Diastolic dysfunction and congestive heart failure. Circulation. 81:1990;Iii1-7.
13. Wheeldon N.M., Clarkson P., MacDonald T.M. Diastolic heart failure. Eur Heart J. 15:1994;1689-1697.
14. Ruzumna P., Gheorghiade M., Bonow R.O. Mechanisms and management of heart failure due to diastolic dysfunction. Curr Opin Cardiol. 11:1996;269-275.
15. How to diagnose diastolic heart failure. Eur Heart J. 19:1998;990-1003.
16. Packer M. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation, 81:1990;Iii78-86.
17. Chan J., Sanderson J., Chan W., et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest. 111:1997;1488-1493.
18. Rakowski H., Appleton C., Chan K.L., et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr. 9:1996;736-760.
19. Henein M.Y., Gibson D.G. Suppression of left ventricular early diastolic filling by long axis asynchrony. Br Heart J. 73:1995;151-157.
20. Giannuzzi P., Imparato A., Temporelli P.L., et al. Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 23:1994;1630-1637.
21. Appleton C.P., Hatle L.K., Popp R.L. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol. 12:1988;426-440.
22. Shimizu Y., Uematsu M., Shimizu H., Nakamura K., Yamagishi M., Miyatake K. Peak negative myocardial velocity gradient in early diastole as a noninvasive indicator of left ventricular diastolic function: comparison with transmitral flow velocity indices. J Am Coll Cardiol. 32:1998;1418-1425.
23. Jensen J.L., Williams F.E., Beilby B.J., et al. Feasibility of obtaining pulmonary venous flow velocity in cardiac patients using transthoracic pulsed wave Doppler technique. J Am Soc Echocardiogr. 10:1997;60-66.
24. Takatsuji H., Mikami T., Urasawa K., et al. A new approach for evaluation of left ventricular diastolic function: spatial and temporal analysis of left ventricular filling flow propagation by color M-mode Doppler echocardiography [see comments]. J Am Coll Cardiol. 27:1996;365-371.
25. Nagueh S.F., Middleton K.J., Spencer W.H., Zoghbi W.A., Quinones M.A. Doppler estimation of left ventricular filling pressure in patients with hypertrophic cardiomyopathy. Circulation. 99:1999;254-261.
26. Sohn D.W., Chai I.H., Lee D.J., et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 30:1997;474-480.
27. Lindstrom L., Wranne B. Pulsed tissue Doppler evaluation of mitral annulus motion: a new window to assessment of diastolic function. Clin Physiol. 19:1999;1-10.
28. Sohn D.W., Kim Y.J., Kim H.C., Chun H.G., Park Y.B., Choi Y.S. Evaluation of left ventricular diastolic function when mitral E and A waves are completely fused: role of assessing mitral annulus velocity. J Am Soc Echocardiogr. 12:1999;203-208.
29. Oki T., Tabata T., Yamada H., et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation [see comments]. Am J Cardiol. 79:1997;921-928.
30. Blomstrand P., Kongstad O., Broqvist M., Dahlstrom U., Wranne B. Assessment of left ventricular diastolic function from mitral annulus motion, a comparison with pulsed Doppler measurements in patients with heart failure. Clin Physiol. 16:1996;483-493.
31. Kudelka A.M., Turner D.A., Liebson P.R., Macioch J.E., Wang J.Z., Barron J.T. Comparison of cine magnetic resonance imaging and Doppler echocardiography for evaluation of left ventricular diastolic function. Am J Cardiol. 80:1997;384-386.
32. Zerhouni E.A., Parish D.M., Rogers W.J., Yang A., Shapiro E.P. Human heart: tagging with MR imaging - a method for noninvasive assessment of myocardial motion. Radiology. 169:1988;59-63.
33. Stuber M., Schedegger M.B., Fischer S.E., et al. Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation. 100:1999;361-368.
34. Chen Y.T., Chang K.C., Hu W.S., Wang S.J., Chiang B.N. Left ventricular diastolic function in hypertrophic cardiomyopathy: assessment by radionuclide angiography. Int J Cardiol. 15:1987;185-193.
35. Briguori C., Betocchi S., Losi M.A., et al. Noninvasive evaluation of left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol. 81:1998;180-187.
36. Bonow R.O. Radionuclide angiographic evaluation of left ventricular diastolic function. Circulation. 84:1991;I208-1215.
37. Little W.C., Downes T.R., Applegate R.J. Invasive evaluation of left ventricular diastolic performance. Herz. 15:1990;362-376.
38. Paulus W.J., Vantrimpont P.J., Rousseau M.F. Diastolic function of the nonfilling human left ventricle [see comments]. J Am Coll Cardiol. 20:1992;1524-1532.
39. Yellin E.L., Hori M., Yoran C., Sonnenblick E.H., Gabbay S., Frater R.W. Left ventricular relaxation in the filling and nonfilling intact canine heart. Am J Physiol. 250:1986;H620-629.
40. Little W.C., Downes T.R. Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis. 32:1990;273-290.
41. Hess O.M., Ritter M., Schneider J., Grimm J., Turina M., Krayenbuehl H.P. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation. 69:1984;855-865.
42. Nakashima Y., Nii T., Ikeda M., Arakawa K. Role of left ventricular regional nonuniformity in hypertensive diastolic dysfunction. J Am Coll Cardiol. 22:1993;790-795.
43. Lamb H.J., Beyerbacht H.P., van der Laarse A., et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation. 99:1999;2261-2267.
44. Obert P., Stecken F., Courteix D., Lecoq A.M., Guenon P. Effect of long-term intensive endurance training on left ventricular structure and diastolic function in prepubertal children. Int J Sports Med. 19:1998;149-154.
45. Koide M., Carabello B.A., Conrad C.C., et al. Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation. Am J Physiol. 276:1999;H350-H358.
46. Sadoshima J., Xu Y., Slayter H.S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
47. Susic D., Nunez E., Frohlich E.D., Prakash O. Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension. 28:1996;265-268.
48. Vasan R.S., Levy D. The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Arch Intern Med. 156:1996;1789-1796.
49. Bronzwaer J.G., de Bruyne B., Ascoop C.A., Paulus W.J. Comparative effects of pacing-induced and balloon coronary occlusion ischemia on left ventricular diastolic function in man. Circulation. 84:1991;211-222.
50. Carroll J.D., Hess O.M., Hirzel H.O., Turina M., Krayenbuehl H.P. Effects of ischemia, bypass surgery and past infarction on myocardial contraction, relaxation and compliance during exercise. Am J Cardiol. 63:1989;65e-71e.
51. Poulsen S.H., Jensen S.E., Egstrup K. Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction. Am Heart J. 137:1999;910-918.
52. Heyndrickx G.R., Paulus W.J. Effect of asynchrony on left ventricular relaxation. Circulation. 81:1990;Iii41-47.
53. Zieman S.J., Fortuin N.J. Hypertrophic and restrictive cardiomyopathies in the elderly. Cardiol Clin. 17:1999;159-172.
54. Hausdorf G., Siglow V., Nienaber C.A. Effects of increasing afterload on early diastolic dysfunction in hypertrophic non-obstructive cardiomyopathy. Br Heart J. 60:1988;240-246.
55. Gwathmey J.K., Warren S.E., Briggs G.M., et al. Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest. 87:1991;1023-1031.
56. Paulus W.J., Heyndrickx G.R., Nellens P., Andries E. Impaired relaxation of the hypertrophied left ventricle in aortic stenosis: effects of aortic valvuloplasty and of postextrasystolic potentiation. Eur Heart J. 9:(Suppl E):1988;25-30.
57. Villari B., Hess O.M., Kaufmann P., Krogmann O.N., Grimm J., Krayenbuehl H.P. Effect of aortic valve stenosis (pressure overload) and regurgitation (volume overload) on left ventricular systolic and diastolic function. Am J Cardiol. 69:1992;927-934.
58. Villari B., Campbell S.E., Hess O.M., et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol. 22:1993;1477-1484.
59. Villari B., Vassalli G., Monrad E.S., Chiariello M., Turina M., Hess O.M. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation. 91:1995;2353-2358.
60. Hess O.M., Villari B., Krayenbuehl H.P. Diastolic dysfunction in aortic stenosis. Circulation. 87:1993;73-76.
61. Monrad E.S., Hess O.M., Murakami T., Nonogi H., Corin W.J., Krayenbuehl H.P. Abnormal exercise hemodynamics in patients with normal systolic function late after aortic valve replacement. Circulation. 77:1988;613-624.
62. Dumesnil J.G., Gaudreault G., Honos G.N., Kingma J.G. Jr. Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol. 68:1991;515-519.
63. Caramelli B., dos Santos R.D., Abensur H., et al. Beta-blocker infusion did not improve left ventricular diastolic function in myocardial infarction: a Doppler echocardiography and cardiac catheterization study. Clin Cardiol. 16:1993;809-814.
64. Gottdiener J.S. Clinical trials of single-drug therapy for the cardiac effects of hypertension. Am J Hypertens. 12:1999;12s-18s.
65. Betocchi S., Chiariello M. Effects of calcium antagonists on left ventricular structure and function. J Hypertens Suppl. 11:1993;S33-37.
66. Iliceto S. Left ventricular dysfunction: which role for calcium antagonists? Eur Heart J. 18:(Suppl A):1997;87-91.
67. Rosing D.R., Idanpaan Heikkila U., Maron B.J., Bonow R.O., Epstein S.E. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy. Am J Cardiol. 55:1985;185b-195b.
68. Mitsunami K., Inoue S., Maeda K., et al. Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension. Cardiovasc Drugs Ther. 12:(AT1):1998;469-474.
69. Angomachalelis N., Hourzamanis A.I., Sideri S., Serasli E., Vamvalis C. Improvement of left ventricular diastolic dysfunction in hypertensive patients 1 month after ACE inhibition therapy: evaluation by ultrasonic automated boundary detection. Heart Vessels. 11:1996;303-309.
70. Kahan T. The importance of left ventricular hypertrophy in human hypertension. J Hypertens Suppl. 16:1998;S23-29.
71. Ramirez Gil J.F., Delcayre C., Robert V., et al. In vivo left ventricular function and collagen expression in aldosterone/salt-induced hypertension. J Cardiovasc Pharmacol. 32:1998;927-934.
72. Silvestre J.S., Heymes C., Oubenaissa A., et al. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation. 99:1999;2694-2701.
73. Degre S., Detry J.M., Unger P., Cosyns J., Brohet C., Kormoss N. Effects of spironolactone-altizide on left ventricular hypertrophy. Acta Cardiol. 53:1998;261-267.
74. Matter C.M., Mandinov L., Kaufmann P.A., Vassalli G., Jiang Z., Hess O.M. Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy. Circulation. 99:1999;2396-2401.
75. Pitt D., Zannad F., Remme W.J., et al. The effect of Spironolacton on morbidity and mortality in patients with severe heart failure. New Engl J Med. 341:1999;709-717.